病例报告:皮里达本中毒诱发了急性呼吸和循环衰竭
Dan Zhang1, Juan Wang2, WeiYi Zhang1
1Shenzhen Yantian District People's Hospital, Shenzhen, 518000, China.
International journal of emergency medicine
|October 1, 2025
概括
本案例报告详细介绍了一例罕见的人类急性pyridaben中毒案例. 迅速的医疗干预,包括胃洗和支持性护理,导致完全康复,没有持久的影响.
科学领域:
- 毒理学 毒理学 毒理学
- 环境科学 环境科学
- 医学 医学 医学 医学 医学
背景情况:
- 皮里达本是一种皮里达津杀虫剂,可以抑制线粒体复合体I.
- 暴露于皮里达本可以导致线粒体功能障碍,细胞缺氧,乳酸,神经毒性和心脏毒性.
- 这种杀虫剂在农业中广泛用于作物保护.
研究的目的:
- 报告一种罕见的皮里达摄入导致人体急性中毒的病例.
- 描述pyridaben中毒的临床表现和管理.
- 突出支持性护理在治疗农药中毒方面的有效性.
主要方法:
- 一名55岁的男性摄入了10毫升的pyridaben.
- 患者出现吐和昏迷,进展为低氧化和低血压.
- 治疗包括胃洗,活性炭,呼吸/循环支持和持续置换疗法 (CRRT).
主要成果:
- 患者出现了pyridaben中毒的严重症状,包括昏迷,低氧化和低血压.
- 迅速启动了积极的支持性管理.
- 患者已成功出院,没有任何残留健康问题.
结论:
- 人类急性中毒pyridaben是一个罕见但严重的事件.
- 及时和全面的支持性护理,包括CRRT,对于管理严重的pyridaben中毒至关重要.
- 这一案例强调了识别和有效治疗新型合成农药中毒的重要性.
关键词:
急性呼吸道急性呼吸道急性呼吸道这就是CRRT.CRRT.CRRT.循环故障的循环故障血 perfusion 输血 输血 输血 输血 输血 输血 输血 输血在Pyridaben中,我们可以看到Pyridaben.更多相关视频
06:22Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS
Published on: April 7, 2021
3.8K
04:10Author Spotlight: Exploring Venous Waveforms for Non-Invasive Respiratory Monitoring in Pigs
Published on: March 8, 2024
1.8K
相关概念视频
Anticholinesterase Agents: Poisoning and Treatment
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Acute Respiratory Failure-I
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-II
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-III
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Acute Respiratory Failure-IV
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
Acute Respiratory Failure-V
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
